Non-histone lysine acetylated proteins in heart failure

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 4, 2012, Pages 607-614

  Grillon, Jean Michel ^a   Johnson, Keven R ^b   Kotlo, Kumar ^a   Danziger, Robert S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Research and Development   (United States)

Author keywords

Global screening; Heart failure; Lysine acetylation; Mitochondrial protein; Sirtuin 3

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; CREATINE KINASE; LYSINE; MALATE DEHYDROGENASE; MITOCHONDRIAL ENZYME; NONHISTONE PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PYRUVATE DEHYDROGENASE; SIRTUIN 3;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HEART LEFT VENTRICLE OVERLOAD; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACETYLATION; ANIMALS; HEART FAILURE; HISTONES; LYSINE; MUSCLE PROTEINS; RATS; RATS, INBRED SHR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

RATTUS; RODENTIA;

EID: 84857136130     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.11.016     Document Type: Article

References (28)

1. Backs J., Olson E.N. Control of cardiac growth by histone acetylation/deacetylation. Circ. Res. 2006, 98:15.
2. Bell E.L., Guarente L. The SirT3 divining rod points to oxidative stress. Mol. Cell 2011, 42:561.
3. Buchwald A., Till H., Unterberg C., Oberschmidt R., Figulla H.R., Wiegand V. Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy. Eur. Heart J. 1990, 11:509.
4. Bugger H., Schwarzer M., Chen D., Schrepper A., Amorim P.A., Schoepe M., Nguyen T.D., Mohr F.W., Khalimonchuk O., Weimer B.C., Doenst T. Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc. Res. 2010, 85:376.
5. Bush E.W., McKinsey T.A. Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors. Circ. Res. 2010, 106:272.
6. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325:834.
7. Gusterson R.J., Jazrawi E., Adcock I.M., Latchman D.S. The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J. Biol. Chem. 2003, 278:6838.
8. Hallows W.C., Lee S., Denu J.M. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10230.
9. Heyen J.R., Blasi E.R., Nikula K., Rocha R., Daust H.A., Frierdich G., Van Vleet J.F., De C.P., McMahon E.G., Rudolph A.E. Structural, functional, and molecular characterization of the SHHF model of heart failure. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1775-H1784.
10. Hirschey M.D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D.B., Grueter C.A., Harris C., Biddinger S., Ilkayeva O.R., Stevens R.D., Li Y., Saha A.K., Ruderman N.B., Bain J.R., Newgard C.B., Farese R.V., Alt F.W., Kahn C.R., Verdin E. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121.
11. Inoko M., Kihara Y., Morii I., Fujiwara H., Sasayama S. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am. J. Physiol. 1994, 267:H2471-H2482.
12. Iwabata H., Yoshida M., Komatsu Y. Proteomic analysis of organ-specific post-translational lysine-acetylation and -methylation in mice by use of anti-acetyllysine and -methyllysine mouse monoclonal antibodies. Proteomics 2005, 5:4653.
13. Kee H.J., Kook H. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy. J. Biomed. Biotechnol. 2011, 2011:928326.
14. Kerner J., Lee K., Hoppel C.L. Post-translational modifications of mitochondrial outer membrane proteins. Free Radic. Res. 2011, 45:16.
15. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.J., Zhao Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23:607.
16. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.J., Zhao Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23:607.
17. Lin G., Liu Y., MacLeod K.M. Regulation of muscle creatine kinase by phosphorylation in normal and diabetic hearts. Cell. Mol. Life Sci. 2009, 66:135.
18. Marin-Garcia J., Goldenthal M.J., Moe G.W. Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. Cardiovasc. Res. 2001, 52:103.
19. Ozden O., Park S.H., Kim H.S., Jiang H., Coleman M.C., Spitz D.R., Gius D. Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress. Aging (Albany, NY) 2011, 3:102.
20. Peters T.J., Brooksby I.A., Webb-Peploe M.M., Wells G., Jenkins B.S., Coltart D.J. Enzymic analysis of cardiac biopsy material from patients with valvular heart-disease. Lancet 1976, 1:269.
21. Pillai V.B., Sundaresan N.R., Jeevanandam V., Gupta M.P. Mitochondrial SIRT3 and heart disease. Cardiovasc. Res. 2010, 88:250.
22. Rennison J.H., McElfresh T.A., Okere I.C., Patel H.V., Foster A.B., Patel K.K., Stoll M.S., Minkler P.E., Fujioka H., Hoit B.D., Young M.E., Hoppel C.L., Chandler M.P. Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure. Cardiovasc. Res. 2008, 79:331.
23. Schwer B., Bunkenborg J., Verdin R.O., Andersen J.S., Verdin E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10224.
24. Spange S., Wagner T., Heinzel T., Kramer O.H. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int. J. Biochem. Cell Biol. 2009, 41:185.
25. Starai V.J., Celic I., Cole R.N., Boeke J.D., Escalante-Semerena J.C. Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science 2002, 298:2390.
26. Sundaresan N.R., Gupta M., Kim G., Rajamohan S.B., Isbatan A., Gupta M.P. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 2009, 119:2758.
27. Trivedi C.M., Luo Y., Yin Z., Zhang M., Zhu W., Wang T., Floss T., Goettlicher M., Noppinger P.R., Wurst W., Ferrari V.A., Abrams C.S., Gruber P.J., Epstein J.A. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat. Med. 2007, 13:324.
28. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L., Zeng Y., Li H., Li Y., Shi J., An W., Hancock S.M., He F., Qin L., Chin J., Yang P., Chen X., Lei Q., Xiong Y., Guan K.L. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000.